EUR 209.0
(-2.34%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 5.31 Billion EUR | 109.01% |
2022 | 2.54 Billion EUR | 22.44% |
2021 | 2.07 Billion EUR | -0.55% |
2020 | 2.08 Billion EUR | 95.93% |
2019 | 1.06 Billion EUR | 6.03% |
2018 | 1 Billion EUR | 5.2% |
2017 | 954.97 Million EUR | 74.28% |
2016 | 547.93 Million EUR | 38.09% |
2015 | 396.78 Million EUR | 1.2% |
2014 | 392.07 Million EUR | -1.24% |
2013 | 397.01 Million EUR | 15.64% |
2012 | 343.32 Million EUR | 12.26% |
2011 | 305.81 Million EUR | 36.12% |
2010 | 224.67 Million EUR | -20.69% |
2009 | 283.28 Million EUR | 0.0% |
2008 | - EUR | -100.0% |
2007 | 207.36 Million EUR | 232.16% |
2006 | 62.43 Million EUR | -11.54% |
2005 | 70.57 Million EUR | 0.0% |
2004 | - EUR | 0.0% |
2003 | - EUR | 0.0% |
2002 | - EUR | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 4.62 Billion EUR | -11.07% |
2024 Q1 | 5.19 Billion EUR | -2.1% |
2024 Q3 | 4.35 Billion EUR | -2.13% |
2023 FY | 5.31 Billion EUR | 109.01% |
2023 Q4 | 5.31 Billion EUR | -0.98% |
2023 Q3 | 5.36 Billion EUR | 93.4% |
2023 Q2 | 2.77 Billion EUR | 6.48% |
2023 Q1 | 2.6 Billion EUR | 2.49% |
2022 Q3 | 2.57 Billion EUR | 22.03% |
2022 Q4 | 2.54 Billion EUR | -1.4% |
2022 Q1 | 2.05 Billion EUR | -0.86% |
2022 Q2 | 2.11 Billion EUR | 2.63% |
2022 FY | 2.54 Billion EUR | 22.44% |
2021 FY | 2.07 Billion EUR | -0.55% |
2021 Q1 | 2.18 Billion EUR | 4.62% |
2021 Q3 | 2.12 Billion EUR | 0.27% |
2021 Q2 | 2.12 Billion EUR | -2.81% |
2021 Q4 | 2.07 Billion EUR | -2.46% |
2020 Q4 | 2.08 Billion EUR | 0.04% |
2020 Q1 | 1.07 Billion EUR | 1.1% |
2020 FY | 2.08 Billion EUR | 95.93% |
2020 Q2 | 1.86 Billion EUR | 72.74% |
2020 Q3 | 2.08 Billion EUR | 12.15% |
2019 Q2 | 1.09 Billion EUR | 6.91% |
2019 FY | 1.06 Billion EUR | 6.03% |
2019 Q4 | 1.06 Billion EUR | -1.41% |
2019 Q3 | 1.08 Billion EUR | -0.92% |
2019 Q1 | 1.01 Billion EUR | 1.52% |
2018 Q3 | 1.02 Billion EUR | 2.11% |
2018 Q2 | 1 Billion EUR | 3.76% |
2018 FY | 1 Billion EUR | 5.2% |
2018 Q1 | 969.9 Million EUR | 1.56% |
2018 Q4 | 1 Billion EUR | -2.24% |
2017 Q3 | 976.1 Million EUR | -1.62% |
2017 Q2 | 992.2 Million EUR | 5.68% |
2017 Q1 | 938.9 Million EUR | 71.35% |
2017 Q4 | 954.97 Million EUR | -2.16% |
2017 FY | 954.97 Million EUR | 74.28% |
2016 Q1 | 412.8 Million EUR | 4.04% |
2016 Q2 | 560 Million EUR | 35.66% |
2016 FY | 547.93 Million EUR | 38.09% |
2016 Q3 | 560.4 Million EUR | 0.07% |
2016 Q4 | 547.93 Million EUR | -2.22% |
2015 Q4 | 396.78 Million EUR | 7.82% |
2015 Q2 | 353.2 Million EUR | 3.4% |
2015 Q1 | 341.6 Million EUR | -12.87% |
2015 FY | 396.78 Million EUR | 1.2% |
2015 Q3 | 368 Million EUR | 4.19% |
2014 Q2 | 411.2 Million EUR | 5.27% |
2014 Q3 | 411.5 Million EUR | 0.07% |
2014 Q4 | 392.07 Million EUR | -4.72% |
2014 FY | 392.07 Million EUR | -1.24% |
2014 Q1 | 390.6 Million EUR | -1.62% |
2013 Q2 | 379 Million EUR | 6.85% |
2013 Q4 | 397.01 Million EUR | 8.44% |
2013 Q3 | 366.1 Million EUR | -3.4% |
2013 Q1 | 354.7 Million EUR | 3.31% |
2013 FY | 397.01 Million EUR | 15.64% |
2012 FY | 343.32 Million EUR | 12.26% |
2012 Q4 | 343.32 Million EUR | -2.02% |
2012 Q3 | 350.4 Million EUR | -2.99% |
2012 Q2 | 361.2 Million EUR | 17.31% |
2012 Q1 | 307.9 Million EUR | 0.68% |
2011 Q3 | 318.6 Million EUR | 33.87% |
2011 Q2 | 238 Million EUR | 5.87% |
2011 FY | 305.81 Million EUR | 36.12% |
2011 Q4 | 305.81 Million EUR | -4.01% |
2011 Q1 | 224.8 Million EUR | 0.06% |
2010 FY | 224.67 Million EUR | -20.69% |
2010 Q4 | 224.67 Million EUR | -11.16% |
2010 Q3 | 252.9 Million EUR | -6.71% |
2010 Q2 | 271.1 Million EUR | -7.79% |
2010 Q1 | 294 Million EUR | 3.78% |
2009 FY | 283.28 Million EUR | 0.0% |
2009 Q4 | 283.28 Million EUR | 0.0% |
2008 FY | - EUR | -100.0% |
2007 FY | 207.36 Million EUR | 232.16% |
2006 FY | 62.43 Million EUR | -11.54% |
2005 FY | 70.57 Million EUR | 0.0% |
2004 FY | - EUR | 0.0% |
2003 FY | - EUR | 0.0% |
2002 FY | - EUR | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
SCHOTT Pharma AG & Co. KGaA | 72.33 Million EUR | -7243.048% |
Carl Zeiss Meditec AG | 155.69 Million EUR | -3311.327% |
Fielmann Aktiengesellschaft | 652.37 Million EUR | -714.153% |
Gerresheimer AG | 1.04 Billion EUR | -410.06% |
Sartorius Aktiengesellschaft | 5.31 Billion EUR | 0.0% |